New research sheds light on IL-23’s role in chronic inflammatory bowel diseases

FHS
June 13, 2024
3:48 am

Scientists at Weill Cornell Medicine discovered a previously unknown link between two key pathways that regulate the immune system in mammals-;a finding that impacts our understanding of chronic inflammatory bowel diseases (IBD).

Study illuminates new connections between diet and immunity

A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by

July 28, 2023

Bristol Myers to buy cancer player Mirati for more than $4.8 billion

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that

October 9, 2023

Guarding Patient Privacy in the Age of AI Healthcare

Kevin Kirkwood, Deputy CISO, LogRhythm 2022 research from Morning Consult reveals that the healthcare field in particular has witnessed substantial enhancements in medical diagnoses, mental

November 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.